Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
Mu Medical, a medical technology company aiming to support “the full life cycle of ocular care,” is set to be formed out of a partnership between Nanodropper, Bedo Solutions and Viseon Labs, according to a press release from Nanodropper.
“The overarching goal of Mu Medical is to bring precision and personalization to ophthalmology across the full care continuum — from how a therapy is delivered, to how it’s used at home, to how treatment decisions are informed,” the company said in a statement to Healio.
A planned consolidation will integrate the three companies’

